Become a member of the iCMLf – help shape our future

Your support for the iCMLf will further the progress towards best possible management for CML patients wherever they reside. In addition, becoming a member of the iCMLf provides a number of benefits.

The mission of the iCMLf is to improve outcomes for people with CML globally. Formed in 2009 by a leading group of hematologists, the aims of the iCMLf are to foster and coordinate global clinical and research collaborations and to improve CML clinical practice and disease monitoring worldwide.

“The improved survival in CML directly attributable to the use of tyrosine kinase inhibitors is so dramatic that these new agents must be made available to the greatest possible number of eligible patients as rapidly as possible throughout the whole world” John Goldman iCMLf Chairman

There are numerous activities that come within the iCMLf’s broad charter but the initial focus of the Foundation is to address the needs in CML that are not already being met by other groups, particularly those needs that are best met by a global organisation. Even in a disease area with effective treatment, so much still needs to be tackled to make sure that all patients around the world receive the best possible therapy and care.

iCMLf Programs

ERSAP Preceptorship Program - Enhancing clinical knowledge and skills in the treatment of CML through preceptorships at internationally renowned CML centres. This program is a unique opportunity for clinicians from emerging economic countries who treat CML to undertake an intensive educational program to develop and expand their CML management skills.

ERSAP Diagnosis and Testing Program - Through this program the iCMLf assists clinicians in emerging regions use objective testing to diagnose and monitor CML via FISH, cytogenetics, or PCR. Partnerships are established between CML doctors and centres in emerging regions and CML centres of excellence to develop diagnostic and monitoring services. Through this program the iCMLf will enhance facilities at a local level, building capacity to bring high quality testing to the patient.

iCMLf Virtual Education Program - A series of webcast presentations on the practical aspects of CML management. Innovative e-learning tutorials are provided as interactive webcasts on the iCMLf website as well as on USB flash drives for offline use. Leading hematologists provide lectures with updated information on treatment advances, including disease monitoring and new therapies.

Other iCMLf Activities

1. International CML Meeting – Co-sponsored with the European School of Haematology this meeting is entirely focused on the biology and treatment of CML. Bringing together CML experts from around the world speakers present the newest and often unpublished data that relate to CML.
2. Difficult Clinical Case forum - To share and enhance best practice management of CML, clinicians discuss challenging CML patient cases with the iCMLf expert panel.
3. Rowley Prize – Named in honor of Dr Janet Rowley, the annual iCMLf Rowley prize is awarded to a person who has made a major contribution to our understanding of the biology of CML or to the management of patients with CML.

Become an iCMLf Member now!

Through the work of the iCMLf your support will further the progress towards best possible management for CML patients wherever they reside.

Membership of the iCMLf is US$100 annually.

A lesser amount can be contributed if full payment is difficult at this time (minimum $10)

>>> Become a member now - fill out our membership form here! <<<

Benefits of Membership

Members of the iCMLf will:

• Become part of an international network focused on improving outcomes in CML
• Contribute to the global research and educational programs of the iCMLf
• Access a network of international contacts, including leading hematologists and scientists, with a common interest in CML
• Be invited to attend the iCMLf’s regional meetings
• Nominate candidates for the annual iCMLf Rowley prize
• Nominate candidates for the iCMLf Scientific Advisory Committee and National Representative Board
• Have the opportunity to contribute as a reviewer to the scientific publications of the iCMLf
• Submit articles for the iCMLf twice yearly newsletter
• Receive regular updates on the programs and activities of the iCMLf
• Receive the iCMLf Newsletter and annual report

The iCMLf is a charitable organisation registered in England and Wales.

Charity number 1132984.

Donations are tax deducible as allowable by law.

Become a member of the iCMLf – help shape our future

The mission of the iCMLf is to improve outcomes for people with CML globally. Established in 2009 by a leading group of hematologists, the aims of the iCMLf are to foster and coordinate global clinical and research collaborations and to improve CML clinical practice and disease monitoring worldwide. Become a member now!